Zentalis Pharmaceuticals, Inc. (ZNTL) at a glance

Zentalis Pharmaceuticals, Inc. (ZNTL) is a Healthcare company. It trades at $3.79. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Income (40/100).

Price
$3.79
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.13 to $6.95
Vestovix Score50/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
46